Metastatic differentiated thyroid carcinoma: Clinicopathological profile and outcome in an iodine deficient area

被引:0
|
作者
Mishra, A
Mishra, SK
Agarwal, A
Das, BK
Agarwal, G
Gambhir, S
机构
[1] Sanjay Gandhi Postgrad Inst Med Sci, Dept Endocrine Surg, Lucknow 226014, Uttar Pradesh, India
[2] Sanjay Gandhi Postgrad Inst Med Sci, Dept Nucl Med, Lucknow 226014, Uttar Pradesh, India
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
Reports on metastatic differentiated carcinoma in endemic goiter regions are scarce. The aim of this study was to look into the clinicopathological profile and outcome of patients with metastatic differentiated thyroid carcinoma (DTC) of endemic origin. This was a retrospective study of 28 cases of metastatic DTC out of a total of 140 DTC patients managed between 1990 and June 1999. Demographic data, clinicopathological profile, operative and radioiodine ablation therapy details, and follow-up findings were noted. The overall incidence of distant metastases in our series was 20%. Mean age was 48.5 +/- 12.8 years (32.1% patients were < 45 years). Most metastases were detected synchronously (85.7%) and were multiple, with the skeletal system being the commonly affected site. Out of 22 cases having skeletal metastases, 6 patients were young (< 45 years). Though most patients with skeletal metastases had follicular carcinoma (FTC), 4 cases had papillary thyroid cancer (PTC). Near total or total thyroidectomy was done in 26 cases. Sixteen patients required regional lymph node dissection. Resection of metastases was performed in 9 cases. Histopathological diagnosis was PTC, FTC, and poorly differentiated carcinoma in 32.1%, 50.0%, and 17.9% of cases, respectively. Most patients had good symptomatic palliation following administration of I-131 therapy. In 17.9% of cases there were locoregional recurrences. There was an overall 28.6% mortality. Two patients expired in the perioperative period. Six others died in follow-up (all within 3-9 months). In contrast to iodine sufficient regions, the incidence of metastases was high; the majority of cases had synchronous, symptomatic skeletal metastases. Skeletal metastases were not infrequent even in cases of PTC and in young patients. One-third of the cases were young. Though survival was poor despite aggressive management, significant symptomatic palliation could be achieved in most cases.
引用
收藏
页码:153 / 157
页数:5
相关论文
共 50 条
  • [31] Oncocytic Papillary Thyroid Carcinoma and Oncocytic Poorly Differentiated Thyroid Carcinoma: Clinical Features, Uptake, and Response to Radioactive Iodine Therapy, and Outcome
    Lukovic, Jelena
    Petrovic, Irina
    Liu, Zijin
    Armstrong, Susan M.
    Brierley, James D.
    Tsang, Richard
    Pasternak, Jesse D.
    Gomez-Hernandez, Karen
    Liu, Amy
    Asa, Sylvia L.
    Mete, Ozgur
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [32] Clinical outcome in differentiated thyroid carcinoma and microcarcinoma
    Lupoli, Roberta
    Cacciapuoti, Marianna
    Tortora, Anna
    Barba, Livia
    Verde, Nunzia
    Romano, Fiammetta
    Vastarella, Maria
    Fonderico, Francesco
    Masone, Stefania
    Milone, Marco
    Lupoli, Giovanni
    Lupoli, Gelsy Arianna
    INTERNATIONAL JOURNAL OF SURGERY, 2014, 12 : S148 - S151
  • [33] Sorafenib: a review of its use in patients with radioactive iodine-refractory, metastatic differentiated thyroid carcinoma
    Blair, Hannah A.
    Plosker, Greg L.
    TARGETED ONCOLOGY, 2015, 10 (01) : 171 - 178
  • [34] Sorafenib: a review of its use in patients with radioactive iodine-refractory, metastatic differentiated thyroid carcinoma
    Hannah A. Blair
    Greg L. Plosker
    Targeted Oncology, 2015, 10 : 171 - 178
  • [35] Predictive factors and clinicopathological characteristics of outcome in poorly differentiated thyroid carcinoma: a single-institution study
    Wan, Zheng
    Wang, Bing
    Yao, Jing
    Li, Qing
    Miao, Xin
    Jian, Yanbing
    Huang, Sisi
    Lai, Shengwei
    Li, Chen
    Tian, Wen
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [36] The clinicopathological significance of histologic vascular invasion in differentiated thyroid carcinoma
    Nishida, T
    Katayama, S
    Tsujimoto, M
    AMERICAN JOURNAL OF SURGERY, 2002, 183 (01): : 80 - 86
  • [37] The Predictive Value of Postoperative Serum Thyroglobulin in the Outcome of Radioactive Iodine-131 Thyroid Ablation in Differentiated Thyroid Carcinoma
    Elrasad, S. A. A.
    Abdelhafez, Y. G.
    Tawakol, A.
    Nawwar, A.
    El-Refaei, S. M. A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S373 - S373
  • [38] Is serum TSH a biomarker of thyroid carcinoma in patients residing in a mildly iodine-deficient area?
    Kristine Zøylner Swan
    Viveque Egsgaard Nielsen
    Christian Godballe
    Jens Faunø Thrane
    Marie Riis Mortensen
    Sten Schytte
    Henrik Baymler Pedersen
    Peer Christiansen
    Steen Joop Bonnema
    Endocrine, 2018, 61 : 308 - 316
  • [39] Is serum TSH a biomarker of thyroid carcinoma in patients residing in a mildly iodine-deficient area?
    Swan, Kristine Zoylner
    Nielsen, Viveque Egsgaard
    Godballe, Christian
    Thrane, Jens Fauno
    Mortensen, Marie Riis
    Schytte, Sten
    Pedersen, Henrik Baymler
    Christiansen, Peer
    Bonnema, Steen Joop
    ENDOCRINE, 2018, 61 (02) : 308 - 316
  • [40] DEVELOPMENT OF CARCINOMA OF THYROID IN IODINE-DEFICIENT MICE
    SCHALLER, RT
    STEVENSON, JK
    CANCER, 1966, 19 (08) : 1063 - +